Patients Hospitalized With COVID-19 Had Fewer Oxygen Days With Fostamatinib
A clinical trial of fostamatinib showed it was safe and effective for treating patients hospitalized with COVID-19 receiving oxygen.
A clinical trial of fostamatinib showed it was safe and effective for treating patients hospitalized with COVID-19 receiving oxygen.
Researchers analyzed the relationship between cough severity in fibrotic ILD and patients’ baseline clinical parameters, disease progression, and prognosis.
Researchers characterized the clinical features, treatment regimens, and demographics of patients with asthma who initiated MITT and subsequently quit vs continued.
Previously, the treatment had only been approved for patients 12 years and older.
Findings seen among patients with resected ALK-positive non-small cell lung cancer
Black race, food allergies, allergic rhinitis significantly associated with new diagnosis of asthma
Researchers explored the cardiovascular benefit vs harm of prescribing CPAP in patients with acute coronary syndrome and nonsleepy OSA.
Researchers assessed whether the lower boundary of FEV1 varied by race and whether race affected the link between FEV1Q and mortality.
Researchers evaluated which medical conditions were associated with breathlessness in a population of middle-aged adults.
Researchers assessed whether risk scores originally developed for PAH had prognostic value for patients in pulmonary hypertension groups 1 to 4.
Researchers compared the efficacy and safety of rifampicin flat-dosing vs weight-banded dosing in patients with TB.